Projects

Use of Second-Generation Basal Insulin Gla-300 in Special Populations:

Groups and Associations Sujoy Ghosh, Sanjay Kalra, Ganapathi Bantwal, Rakesh Kumar Sahay
Curr Diabetes Rev . 2023

Background and aims: Hypoglycemia and insulin-related adverse events are crucial barriers to effective diabetes management, particularly in the elderly, people with renal impairment, people with diabetes fasting during Ramadan, or people with type 1 diabetes mellitus (T1DM). There is a scarcity of clinical and real-world evidence assessing the effectiveness and safety of insulin glargine 300 U/mL (Gla-300) in these special populations. To understand the entirety of evidence, this mini-review elaborates on the use of Gla-300 in diabetes management among special populations.

Book